2 results match your criteria British biotechnology journal[Journal]

  • Page 1 of 1

C-BETA Lactamases among Isolated at a Tertiary Hospital, South Western Uganda.

Br Biotechnol J 2014 Sep;4(9):1026-1036

Department of Microbiology, Mbarara University of Science and Technology, P.O Box 1410, Mbarara, Uganda.

Aim: To characterize -beta lactamases among isolates from clinical samples at Mbarara Regional Referral Hospital.

Study Design: Laboratory-based descriptive cross-sectional study.

Place And Duration Of Study: Microbiology Department, Mbarara Regional Referral Hospital and MBN clinical Laboratories, between May to September 2013. Read More

View Article

Download full-text PDF

http://dx.doi.org/10.9734/BBJ/2014/10570DOI Listing
September 2014
14 Reads

Constraining the Pluripotent Fate of Human Embryonic Stem Cells for Tissue Engineering and Cell Therapy - The Turning Point of Cell-Based Regenerative Medicine.

Xuejun H Parsons

Br Biotechnol J 2013 Oct;3(4):424-457

San Diego Regenerative Medicine Institute, San Diego, CA 92109, USA. ; Xcelthera, San Diego, CA 92109, USA.

To date, the lack of a clinically-suitable source of engraftable human stem/progenitor cells with adequate neurogenic potential has been the major setback in developing safe and effective cell-based therapies for regenerating the damaged or lost CNS structure and circuitry in a wide range of neurological disorders. Similarly, the lack of a clinically-suitable human cardiomyocyte source with adequate myocardium regenerative potential has been the major setback in regenerating the damaged human heart. Given the limited capacity of the CNS and heart for self-repair, there is a large unmet healthcare need to develop stem cell therapies to provide optimal regeneration and reconstruction treatment options to restore normal tissues and function. Read More

View Article

Download full-text PDF

http://dx.doi.org/10.9734/BBJ/2013/4309#sthash.6D8Rulbv.dpufDOI Listing
October 2013
20 Reads
  • Page 1 of 1